Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Stern

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Neurology|February 1, 1994
Olfactory function in Parkinson's disease subtypesM B Stern, R L Doty, M Dotti, et al.
Neurology|March 12, 2003
Grammatical and resource components of sentence processing in Parkinson's disease: an fMRI studyM Grossman, A Cooke, C DeVita, et al.
AJR. American Journal of Roentgenology|January 1, 1989
MR imaging of Parkinson disease with spin-echo and gradient-echo sequencesB H Braffman, R I Grossman, H I Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteersP D Mozley, J S Schneider, P D Acton, et al.
The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.
Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.
Neurology|May 24, 2000
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's diseaseH I Hurtig, J Q Trojanowski, J Galvin, et al.
Neurology|May 25, 2005
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson diseaseA Siderowf, A Newberg, K L Chou, et al.
Journal of Neuropathology and Experimental Neurology|September 27, 2000
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophyJ E Duda, B I Giasson, T L Gur, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Neurology|February 1, 1994
Olfactory function in Parkinson's disease subtypesM B Stern, R L Doty, M Dotti, et al.
Neurology|March 12, 2003
Grammatical and resource components of sentence processing in Parkinson's disease: an fMRI studyM Grossman, A Cooke, C DeVita, et al.
AJR. American Journal of Roentgenology|January 1, 1989
MR imaging of Parkinson disease with spin-echo and gradient-echo sequencesB H Braffman, R I Grossman, H I Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2000
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteersP D Mozley, J S Schneider, P D Acton, et al.
The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.
Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.
Neurology|May 24, 2000
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's diseaseH I Hurtig, J Q Trojanowski, J Galvin, et al.
Neurology|May 25, 2005
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson diseaseA Siderowf, A Newberg, K L Chou, et al.
Journal of Neuropathology and Experimental Neurology|September 27, 2000
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophyJ E Duda, B I Giasson, T L Gur, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Pageof 8